Evidence-based Skill and Competency Platform to Include 12 New Categories with More Than 350 Topics

IPSWICH, Mass. , Aug. 10, 2023 /PRNewswire-PRWeb/ — Dynamic Health™, EBSCO Information Services’ (EBSCO) evidence-based skill and competency development tool, has released a new set of leadership content aimed to help point-of-care leaders further develop their leadership skills. Dynamic Health’s new leadership content consists of 12 categories with more than 350 anticipated topics, designed for nurse and health professions leaders looking to take their professional growth and team development to the next level.

Dynamic Health is an evidence-based solution designed to help nurses and health professionals master critical skills, obtain fast answers to questions at the point of care and foster a culture of evidence-based practice and critical thinking to help improve patient outcomes. The new content synthesizes research aimed to build leadership competencies and bring best practices and helpful strategies to the forefront. Categories include case management, finance and budgeting, staffing and scheduling, human resources, and more. Topics will be released over time to ensure thorough, evidence-based information is included.

Dynamic Health Editor in Chief Diane Hanson says this new leadership content is part of ongoing efforts to provide industry-leading point-of-care clinical decision support to the nursing & health professions community. “Dynamic Health is currently the only evidence-based support tool that includes such a full breadth and depth of leadership content. We developed this new set of content with point-of-care leaders in mind and in response to ongoing challenges with retention and the need for expanded educational opportunities. By providing evidence-based education opportunities directly within Dynamic Health, we are helping nurses and health professionals build the skills they need to provide transformational leadership.”

To learn more about Dynamic Health, visit: https://www.ebsco.com/health-care/products/dynamic-health.

About EBSCO Information Services
EBSCO Information Services (EBSCO) is the preeminent provider of online research content and search technologies serving academic, school and public libraries; healthcare and medical institutions; corporations; and government agencies around the world. EBSCO’s Clinical Decisions suite of products are designed to improve patient care by providing healthcare professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care. For more information, visit the EBSCO website at: http://www.ebsco.com.

###

For more information, please contact:
Jessica Holmes
Communications Director
[email protected]
978-414-0420

Media Contact

Jessica Holmes, EBSCO Information Services, 978-414-0420, jmholmes@ebsco.com

SOURCE EBSCO Information Services

BCEN’s Certified Transport Registered Nurse (CTRN) national board certification program for RNs specializing in critical care ground transport has been accredited by the Accreditation Board for Specialty Nursing Certification (ABSNC).

OAK BROOK, Ill., Aug. 10, 2023 /PRNewswire-PRWeb/ — The Board of Certification for Emergency Nursing, the benchmark for specialty excellence across the emergency nursing spectrum, today announced that its Certified Transport Registered Nurse (CTRN) national board certification program for critical care ground transport nurses has been accredited by the Accreditation Board for Specialty Nursing Certification (ABSNC). Accreditation by ABSNC means that the CTRN certification program has met or exceeds the nursing certification industry’s most rigorous standards based on an independent, peer-reviewed process.

RNs play a major role in delivering crucial and often life-preserving or life-saving care to critically ill or injured patients in the dynamic, autonomous and high stakes ground transport environment. To earn the CTRN credential, nurses must demonstrate mastery of advanced ground transport nursing-specific clinical knowledge as well as safety, survival, disaster preparedness, scene operations management, communications, and equipment and vehicle knowledge.

“Excellence in ground transport nursing is crucial to the public emergency response and successful interfacility transfers of critically ill and injured patients,” said BCEN CEO Janie Schumaker, MBA, BSN, RN, CEN, CPHQ, CENP, FABC. “ABSNC accreditation of the CTRN ground transport specialty certification is an important signal to nurses, healthcare teams, institutions, and patients and their families alike.”

The CTRN is BCEN’s fastest growing certification program, increasing by 19% in 2020, 29% in 2021, and 24% in 2022 as well as in 2023 year-to-date. According to a peer-reviewed January/February 2023 Air Medical Journal article, the top three perceived benefits of holding the CTRN are critical thinking in the ground transport environment (88%), confidence as a ground transport nurse (88%), and a sense of accomplishment and pride (95%). Over half (51%) of survey respondents reported doing more ground transports since the start of the pandemic, and nearly two-thirds (62%) said being a CTRN “contributed to their ability to deliver the best possible care” to patients with COVID-19.

“To earn initial accreditation, a certification body must provide detailed data that demonstrates a particular certification program adheres to ABSNC’s 18 accreditation standards including organizational autonomy, basis in a body of research-based knowledge, nondiscrimination, test development, validity, reliability, test administration, test security, fairness of passing score, recertification, and confidentiality,” said BCEN Director of Certification and Accreditation Amy Grand, MSN, RN, ICE-CCP . “We are proud to say that all five of BCEN’s currently available certification programs are now accredited.” BCEN’s new burn nursing credential will launch in Q4 2023.

Additionally:

• The CTRN has been ANCC Magnet-accepted since 2009.
• The Commission on Accreditation of Medical Transport Systems (CAMTS) has recognized the CTRN since 2006 and now requires that RNs hold a transport-specific credential.
• While the number of CTRNs has grown steadily since the credential was introduced in 2006, the number of CTRNs has doubled in just the past three years. Today, over 500 nurses hold the CTRN.

For more on the CTRN and ground transport nursing, read “The Roles and Contributions of Certified Transport Registered Nurses in Critical Care Ground Transport Today” in the March 2022 Air Medical Journal and “Grounded in Excellence: The CTRN“.

For more about ABSNC, the only accrediting body specifically for nursing certifications, and to read ABSNC’s announcement regarding initial accreditation of the CTRN, please visit absnc.org.

About BCEN
Founded in 1980, the independent, not-for-profit Board of Certification for Emergency Nursing (BCEN®) offers robust certification programs fostering empowered nurses across the emergency spectrum who contribute noticeably to patient care, safety and outcomes. Over 59,000 BCEN board certifications are held by registered nurses (RNs) who specialize in emergency, flight, critical care ground transport, pediatric emergency, and trauma nursing. BCEN offers the Certified Emergency Nurse (CEN®), Certified Flight Registered Nurse (CFRN®), Certified Pediatric Emergency Nurse (CPEN®), Certified Transport Registered Nurse (CTRN®) and Trauma Certified Registered Nurse (TCRN®) certifications, all of which are accredited by ABSNC. BCEN’s newest certification, the Certified Burn Registered Nurse (CBRN), will be widely available in Q4 2023. Learn more at bcen.org. Follow BCEN on Facebook, LinkedIn and Instagram.
# # #

Media Contact

Hilde Marnul, Board of Certification for Emergency Nursing, 630-352-0811, [email protected]

LinkedIn, Facebook

SOURCE Board of Certification for Emergency Nursing

The donations supported Feeding America and more than 200 food banks across the nation

PALMYRA, Wis., Aug. 10, 2023 /PRNewswire-PRWeb/ — Standard Process® has announced the donation of 61,000 meals to a network of more than 200 food banks across the nation as part of the company’s ongoing commitment to change lives through whole food nutrition. The donation — which supported Feeding America® — was made possible through the company’s 8th annual One Day, One Bottle, One Meal event, which was held on Thursday, August 3, 2023.

“I look forward to this event every year because it gives us an opportunity to partner with our employees and customers and continue to show what’s possible when people come together” said Standard Process President and CEO Charlie DuBois.

Standard Process has donated one meal for every Standard Process, MediHerb®, and Standard Process Veterinary Formulas™ product sold since the one-day event launched in 2016. The effort has resulted in more than 505,000 donated meals to help fight hunger across the country.

###

About Standard Process Inc.
Standard Process is a third-generation, family-owned company that has been a leader in making whole food-based supplements since 1929. From the company’s certified organic farm at its Palmyra, Wisconsin headquarters to the Nutrition Innovation Center in Kannapolis, North Carolina, Standard Process is committed to clinical science that advances health and changes lives through whole food-based nutrition.

Learn more about Standard Process and find a health care professional who sells company products at: https://www.standardprocess.com/

Media Contact

Kim Horneck, Standard Process, (262) 495-6564, khorneck@standardprocess.com

SOURCE Standard Process

APLA Health has begun construction on the Michael S. Gottlieb Health Center, West Hollywood. APLA Health has named its newest health center in honor of Dr. Gottlieb’s remarkable contributions in the field of HIV/AIDS.

LOS ANGELES, Aug. 10, 2023 /PRNewswire-PRWeb/ — As the country celebrates National Health Care Center Week, APLA Health announces that it has begun construction on its newest health center to be located in the City of West Hollywood.

The Michael S. Gottlieb Health Center, West Hollywood will provide LGBTQ+ primary care services, HIV specialty care, comprehensive sexual health services, and behavioral health services. With ten exam rooms, this will be APLA Health’s largest health center to date.

APLA Health has chosen to name its new health center after Dr. Michael Gottlieb in honor of his remarkable contributions in the scientific response to HIV/AIDS, his activism and philanthropic efforts, and his direct service to people living with the disease.

Dr. Gottlieb was the lead writer of a report in the CDC’s Morbidity and Mortality Weekly Report (MMWR) on a novel immunologic condition affecting five immunocompromised gay patients in Los Angeles in June of 1981. This reported phenomenon would come to be known as AIDS, and the virus that causes it, HIV.

His early involvement cemented his role as a globally recognized HIV/AIDS specialist. Dr. Gottlieb served as Rock Hudson’s physician, and he partnered with Elizabeth Taylor to form the American Foundation for AIDS Research (AmFAR). Dr. Gottlieb previously served on the Board of Directors at APLA Health and has been a medical provider at APLA Health for the past four years. He will be retiring from the medical profession in December of this year.

“Dr. Gottlieb’s scientific contributions in the early days of the epidemic revolutionized how the world understands HIV and AIDS. His work has left an indelible mark on the city of Los Angeles and the global LGBTQ+ community. We are honored that Dr. Gottlieb is concluding his illustrious medical career with us at APLA Health and naming this building in his honor shows our deep appreciation of his dedicated service to the Los Angeles community throughout his remarkable career,” said Craig E. Thompson, CEO of APLA Health.

###

APLA Health restores dignity and trust within underserved communities by providing world-class LGBTQ+ empowering healthcare, HIV specialty care, food, housing, and other essential support services. Since 1983, APLA Health has remained steadfast in its commitment to ending the HIV/AIDS epidemic in our lifetime. The agency, a multi-site operation, includes seven Federally Qualified health Center (FQHC) locations serving more than 18,000 people annually in Los Angeles County, the nation’s most populous. We provide 20 different services including: medical, dental, and behavioral healthcare; HIV specialty care; PrEP counseling and management; health education and HIV prevention; and STD screening and treatment. For people living with HIV, we offer housing support; benefits counseling; home healthcare; and the Vance North Necessities of Life Program food pantry program. Additionally, we are leaders in advocating for policy and legislation that positively impact the LGBTQ+ and HIV communities we serve. For more information on APLA Health please visit https://aplahealth.org

Media Contact

Dino Hainline, APLA Health, (213) 201-1339, [email protected]

SOURCE APLA Health

The International Society for Pharmaceutical Engineering (ISPE) announced eight keynote speakers for the 2023 ISPE Annual Meeting & Expo, taking place 15-18 October in Las Vegas, NV. This signature event brings together top pharmaceutical industry and regulatory leaders offering compelling presentations and interactive discussions on industry-critical technical developments.

NORTH BETHESDA, Md., Aug. 11, 2023 /PRNewswire-PRWeb/ — The International Society for Pharmaceutical Engineering (ISPE) announced eight keynote speakers for the 2023 ISPE Annual Meeting & Expo, occurring 15-18 October in Las Vegas, NV, and virtually. This acclaimed event brings together top pharmaceutical industry and regulatory leaders, offering compelling presentations and interactive discussions on industry-critical technical developments.
The 2023 ISPE Annual Meeting & Expo features a dynamic line-up of thought-provoking keynote presentations led by some of the most prominent names in the pharmaceutical industry.

Confirmed Keynote Speakers:
Pam Cheng – Executive Vice President, Global Operations and Information Technology – AstraZeneca
Pam Cheng is the Executive Vice President, Global Operations and Information Technology, and Chief Sustainability Officer for AstraZeneca. She led AstraZeneca’s Global Operations in developing and supplying 3 billion COVID-19 vaccine doses to more than 170 countries. With oversight across 18 countries, Pam manages manufacturing, supply chain, procurement, IT, and sustainability, leading a team of over 20,000. Prior, she spent 18 years at Merck/MSD in global roles. Pam holds bachelor’s and master’s degrees in chemical engineering from Stevens Institute of Technology and an MBA in marketing from Pace University.

Judy Chou – President and CEO – AltruBio, Inc
Judy Chou, PhD is the CEO, President, and board member of AltruBio, Inc., a clinical-stage biotech company in San Francisco, CA. With a remarkable career in the biomedical industry, she has led global biotech organizations, including Bayer Pharmaceuticals. Judy’s expertise lies in the development and manufacturing of biologics, and she has made significant contributions to breakthrough technologies and accelerated product development. She serves on the boards of Akero Therapeutics, Inc., California Institute of Regenerative Medicines (CIRM), and advisory boards for UC Berkeley Engineering School and Silicon Valley Women in Engineering.

David Churchward – Global Head Sterility Assurance, Cell and Gene Technologies – Lonza Biologics
David Churchward is the Global Head of Sterility Assurance for Lonza Biologics’ cell and gene technologies business unit. With extensive experience in regulatory collaboration and international harmonization, David ensures sterility assurance standards for manufacturing cell therapies and viral vector products. He previously served as a GMP inspector with the UK MHRA and contributed to major regulatory initiatives.

Kyle Haraldsen – Chief Technology Officer – Lyndra Therapeutics
Kyle Haraldsen is the Chief Technology Officer of Lyndra Therapeutics. With over 20 years of industry experience, he leads product and platform R&D activities, including the development of the LYNX™ drug delivery platform. Kyle has a strong background in technical operations, product development, and project management, having held leadership positions at Saniona and AMAG Pharmaceuticals.

Celia Lourenco – Acting Associate Assistant Deputy Minister – Health Canada
Celia Lourenco, PhD, is the Acting Associate Assistant Deputy Minister for the Health Products and Food Branch of Health Canada. With extensive experience in drug regulation, Celia provides strategic direction for health product and food regulation. She has engaged with international regulatory authorities and co-chaired the COVID-19 working group at the International Coalition of Medicines Regulatory Authorities.

Flavius Martin – Executive Vice President of Research – Gilead Sciences, Inc
Flavius Martin is the Executive Vice President of Research at Gilead Sciences, Inc. In this role, he oversees innovative research and preclinical programs across therapeutic areas. With nearly 20 years in the biopharmaceutical industry, Flavius has held leadership positions at Amgen and Genentech, contributing to advancements in oncology, inflammation, and cardiometabolic research.

Matthew Pearl – Patient Advocate – Fanconi Anemia Research Fund & EveryLife Foundation
Matthew Pearl is a remarkable patient advocate and a dedicated contributor to various nonprofits who captivates audiences worldwide, sharing his invaluable insights and inspiring the Rare Disease Community. His commitment extends to organizations such as the Fanconi Anemia Research Fund, the Rare Action Network, the National Organization for Rare Disorders, and the National Ability Center. Matthew’s groundbreaking research at the Dana Farber Cancer Institute at Harvard, where he was the first Fanconi Anemia (FA) patient to investigate FA, has garnered international recognition.

Michael Lee Sherwood – Chief Innovation and Technology Officer – City of Las Vegas
Michael Lee Sherwood has over 20 years of experience in process improvement, technology, and innovation. As the Chief Innovation and Technology Officer for the City of Las Vegas, he drives initiatives to create brighter and more sustainable communities through collaboration and workforce development. Michael previously served as the Deputy Director of Public Safety, Business Services & City Technology for the City of Irvine, California.

Learn more and register for the 2023 ISPE Annual Meeting & Expo today.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 20,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.

Media Contact

Jessica Bleess, ISPE, 813-739-2289 x280, [email protected]

SOURCE ISPE

The company’s GA4 integration is now available, enabling its life science customers to gain even more insights into the performance of a brand’s digital messaging to healthcare professionals.

GARDEN CITY, N.Y., Aug. 11, 2023 /PRNewswire-PRWeb/ — Pulse Health, a leading provider of cloud-based technology and services for the life science industry, announced that it has completed its integration of Google Analytics 4 (GA4) within the Pulse Engagement Cloud. This feature is immediately available to all customers.

Pulse Health’s Google Analytics 4 Integration will give users a more complete way to understand the impact of the brand’s non-personal messaging to its healthcare professionals, allowing deeper insight and visibility into visitor interactions. The GA4 plugin reinforces Pulse Health’s overall commitment to providing its clients with the most robust offering of integrations, whether pharma focused or generalized technologies.

“With the launch of GA4, our life science clients will have a deeper understanding of how their audience is engaging and with what content. As always, we’ll continue powering their HCP messaging via email, SMS, banners, all while providing even more visibility to their overall traffic data.” said Ryan Alovis, Chief Executive Officer of Pulse Health. “There is a CRM blind spot when it comes to the emerging biotech, or small to mid-size pharma companies, and we want them to know that we’re purpose built to help them grow.”

Widely known as the only life science focused omnichannel platform that offers an emphasis on NPI-driven integrations, quality HCP and patient data, all with built-in customer support to assist in executing and monitoring campaigns. The platform has a proven track record of upping script lift, most recently finalizing a third-party impact review, showing Pulse was responsible for yielding a 15% lift in scripts written for one of their brands. Pulse Health is committed to bringing effective solutions to an industry that is plagued with inefficiencies ranging from disparate data sources to the reliance of multiple single-feature industry generic platforms, absentee client support, or the inability to access actionable data in real-time.

In addition to the GA4 integration, Pulse Health has recently announced its integration with Smarty Streets, enabling its pharma partners to validate over 160 million USPS addresses plus over 15 million non-postal addresses. By offering Smarty Streets via the Pulse Engagement Cloud, customers can have access to real-time hygiene to maintain the highest quality database and optimization of tactic delivery.

For more information on how Pulse Health is powering digital engagement for the life science industry, visit https://pulsehealth.tech/

About Pulse Health

Pulse Health is an industry leader in cloud-based non-personal promotional engagement software and services for the life science industry. Powering a brands journey from launch to life. Pulse Health’s suite of products range from Pulse Engagement Cloud, Pulse Sample Management, Pulse HCP & Patient Data Access, Pulse Insights, and Pulse MCM Tactics. Pulse Health’s client base range from emerging biotech bringing their brands to commercialization, to global pharmaceutical companies looking to amplify their existing brands.

Media Contact

Krissy Goelz, Pulse Health, (888) 888-4115, [email protected]

LinkedIn

SOURCE Pulse Health